Hughes Hubbard is serving as legal counsel to drugmaker Cipla in its pending acquisition of U.S.-based specialty pharmaceutical firm Avenue Therapeutics.

The firm achieved a victory for Macquarie when a Manhattan federal judge threw out claims against the Australian investment bank for alleged manipulation of Singapore's benchmark interest rates.

​Hughes Hubbard earned a significant victory for the Japanese specialty steel industry when the U.S. International Trade Commission ended anti-dumping duties on stainless steel bars from Japan.

Hughes Hubbard is advising Singapore-based Grab in the sale of a $1 billion stake to Toyota Motor Corp. -- the biggest ever investment by an automaker in a ride-hailing firm.

In an appeal being closely watched by the pharmaceutical industry, the firm helped Merck convince the U.S. Supreme Court that it should hear the pharmaceutical giant's appeal of a Third Circuit ruling that revived hundreds of lawsuits over Merck's alleged failure to warn about a risk of thigh bone fractures from its osteoporosis drug Fosamax.

Hughes Hubbard was recognized as one of the best firms for minority attorneys in Law360's 2018 Diversity Snapshot.